Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. The company is viewed as global leader spearheading this exciting new field. With Micreos endolysin technology, for the first time we can kill only the unwanted bacteria - including antibiotic resistant strains - while preserving the beneficial bacteria, essential for our health. In addition, scientists do not expect emergence of resistance against endolysins, based on their working mechanism. This unlocks a completely new approach in dealing with the bacteria around us - also enabling preventive daily therapy against only unwanted bacteria for as long as needed.

logo UtrechtInc

Contactgegevens

A. van Leeuwenhoeklaan 9

Gebouw SR
3721 MA Bilthoven
The Netherlands
+31 (0) 88 800 7100 (EN/NL)
+49 (0) 39 292 6782 65 (DE)

E-mail: info@gladskin.com
www.gladskin.com